Low-potency glucocorticoid hydrocortisone has similar neurotoxic effects as high-potency glucocorticoid dexamethasone on neurons in the immature chicken cerebellum

Brain Research

Volumn 1236, Issue , 2008, Pages 39-48

  Aden, Petra ^a   Goverud, Ingeborg ^a   Liestøl, Knut ^b   Løberg, Else Marit ^a   Paulsen, Ragnhild E ^b   Mæhlen, Jan ^a   Lømo, Jon ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cerebellar development; Glucocorticoids; Neurotoxicity

Indexed keywords

CASPASE 3; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BRAIN NERVE CELL; CELL DEATH; CEREBELLUM; CEREBELLUM CORTEX; CHICKEN; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG SAFETY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; GENETIC TRANSFECTION; GRANULE CELL; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 53049085050     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.07.095     Document Type: Article

References (31)

1. Ahlbom E., Gogvadze V., Chen M., Celsi G., and Ceccatelli S. Prenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell death. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 14726-14730
2. Bohn M.C., and Lauder J.M. Cerebellar granule cell genesis in the hydrocortisone-treated rats. Dev. Neurosci. 3 (1980) 81-89
3. Bolt R.J., van Weissenbruch M.M., Lafeber H.N., and Delemarre-van de Waal H.A. Glucocorticoids and lung development in the fetus and preterm infant. Pediatr. Pulmonol. 32 (2001) 76-91
4. Chen F., Watson C.S., and Gametchu B. Association of the glucocorticoid receptor alternatively-spliced transcript 1A with the presence of the high molecular weight membrane glucocorticoid receptor in mouse lymphoma cells. J. Cell. Biochem. 74 (1999) 430-446
5. Crowther C.A., Doyle L.W., Haslam R.R., Hiller J.E., Harding J.E., and Robinson J.S. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N. Engl. J. Med. 357 (2007) 1179-1189
6. Giguere V., Hollenberg S.M., Rosenfeld M.G., and Evans R.M. Functional domains of the human glucocorticoid receptor. Cell 46 (1986) 645-652
7. Halliday H.L., Ehrenkranz R.A., and Doyle L.W. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst. Rev (2003) CD001144
8. Hamburger V., and Hamilton H.L. A series of normal stages in the development of the chick embryo. 1951. Dev. Dyn. 195 (1992) 231-272
9. Haynes L.E., Griffiths M.R., Hyde R.E., Barber D.J., and Mitchell I.J. Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders. Neuroscience 104 (2001) 57-69
10. Jacobs C.M., Aden P., Mathisen G.H., Khuong E., Gaarder M., Loberg E.M., Lomo J., Maehlen J., and Paulsen R.E. Chicken cerebellar granule neurons rapidly develop excitotoxicity in culture. J. Neurosci. Methods 156 (2006) 129-135
11. + in cerebellar granule neurons. Brain Res. 1070 (2006) 116-123
12. Johnson L.R., Farb C., Morrison J.H., McEwen B.S., and LeDoux J.E. Localization of glucocorticoid receptors at postsynaptic membranes in the lateral amygdala. Neuroscience 136 (2005) 289-299
13. Mager D.E., Lin S.X., Blum R.A., Lates C.D., and Jusko W.J. Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics. J. Clin. Pharmacol. 43 (2003) 1216-1227
14. Mitchell I.J., Cooper A.J., Griffiths M.R., and Barber D.J. Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: a neural substrate for psychosis. Neuroscience 84 (1998) 489-501
15. Nakada M.T., Stadel J.M., Poksay K.S., and Crooke S.T. Glucocorticoid regulation of beta-adrenergic receptors in 3T3-L1 preadipocytes. Mol. Pharmacol. 31 (1987) 377-384
16. O'Shea T.M., Kothadia J.M., Klinepeter K.L., Goldstein D.J., Jackson B.G., Weaver III R.G., and Dillard R.G. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 104 (1999) 15-21
17. Powell C.E., Watson C.S., and Gametchu B. Immunoaffinity isolation of native membrane glucocorticoid receptor from S-49++ lymphoma cells: biochemical characterization and interaction with Hsp 70 and Hsp 90. Endocrine 10 (1999) 271-280
18. Rademaker K.J., Uiterwaal C.S., Groenendaal F., Venema M.M., van B.F., Beek F.J., van I.H., Grobbee D.E., and de Vries L.S. Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children. J. Pediatr. 150 (2007) 351-357
19. Rakic P., and Sidman R.L. Histogenesis of cortical layers in human cerebellum, particularly the lamina dissecans. J. Comp. Neurol. 139 (1970) 473-500
20. Reagan L.P., and McEwen B.S. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. J. Chem. Neuroanat. 13 (1997) 149-167
21. Robson A.C., Leckie C.M., Seckl J.R., and Holmes M.C. 11 Beta-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Brain Res. Mol. Brain Res. 61 (1998) 1-10
22. Shinwell E.S., Karplus M., Reich D., Weintraub Z., Blazer S., Bader D., Yurman S., Dolfin T., Kogan A., Dollberg S., Arbel E., Goldberg M., Gur I., Naor N., Sirota L., Mogilner S., Zaritsky A., Barak M., and Gottfried E. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch. Dis. Child. Fetal Neonatal. Ed. 83 (2000) F177-F181
23. Slagsvold H.H., Ostvold A.C., Fallgren A.B., and Paulsen R.E. Nuclear receptor and apoptosis initiator NGFI-B is a substrate for kinase ERK2. Biochem. Biophys. Res. Commun. 291 (2002) 1146-1150
24. Stahn C., Lowenberg M., Hommes D.W., and Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol. Cell. Endocrinol. 275 (2007) 71-78
25. Subhedar N.V., Duffy K., and Ibrahim H. Corticosteroids for treating hypotension in preterm infants. Cochrane Database Syst. Rev (2007) CD003662
26. Takahashi T., Kimoto T., Tanabe N., Hattori T.A., Yasumatsu N., and Kawato S. Corticosterone acutely prolonged N-methyl-d-aspartate receptor-mediated Ca2+ elevation in cultured rat hippocampal neurons. J. Neurochem. 83 (2002) 1441-1451
27. Tanaka H., Hirano F., Nomura Y., Miura T., Makino Y., Fukawa E., and Makino I. Relative glucocorticoid potency revisited. Rheumatol. Int. 14 (1994) 9-12
28. Uno H., Lohmiller L., Thieme C., Kemnitz J.W., Engle M.J., Roecker E.B., and Farrell P.M. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus Brain Res. Dev. Brain Res. 53 (1990) 157-167
29. Wapner R.J., Sorokin Y., Mele L., Johnson F., Dudley D.J., Spong C.Y., Peaceman A.M., Leveno K.J., Malone F., Caritis S.N., Mercer B., Harper M., Rouse D.J., Thorp J.M., Ramin S., Carpenter M.W., and Gabbe S.G. Long-term outcomes after repeat doses of antenatal corticosteroids. N. Engl. J. Med. 357 (2007) 1190-1198
30. Watson C.S., and Gametchu B. Proteins of multiple classes may participate in nongenomic steroid actions. Exp. Biol. Med. (Maywood). 228 (2003) 1272-1281
31. Yeh T.F., Lin Y.J., Lin H.C., Huang C.C., Hsieh W.S., Lin C.H., and Tsai C.H. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N. Engl. J. Med. 350 (2004) 1304-1313